Krsnaa Diagnostics Balance Sheet Health
Financial Health criteria checks 6/6
Krsnaa Diagnostics has a total shareholder equity of ₹8.4B and total debt of ₹2.2B, which brings its debt-to-equity ratio to 25.7%. Its total assets and total liabilities are ₹12.9B and ₹4.5B respectively. Krsnaa Diagnostics's EBIT is ₹963.1M making its interest coverage ratio 16.1. It has cash and short-term investments of ₹626.2M.
Key information
25.70%
Debt to equity ratio
₹2.16b
Debt
| Interest coverage ratio | 16.1x |
| Cash | ₹626.23m |
| Equity | ₹8.41b |
| Total liabilities | ₹4.54b |
| Total assets | ₹12.95b |
Recent financial health updates
Recent updates
There's Been No Shortage Of Growth Recently For Krsnaa Diagnostics' (NSE:KRSNAA) Returns On Capital
Mar 21
Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 17
Expansion Into Underpenetrated Markets Will Increase Access To Advanced Diagnostic Services
Feb 06 Expansion into Tier 2 and 3 cities and strategic partnerships in healthcare sectors are expected to drive revenue growth and improve profit margins.After Leaping 30% Krsnaa Diagnostics Limited (NSE:KRSNAA) Shares Are Not Flying Under The Radar
Nov 26Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Sep 06Krsnaa Diagnostics (NSE:KRSNAA) Has Announced That Its Dividend Will Be Reduced To ₹2.50
Aug 23Krsnaa Diagnostics Limited (NSE:KRSNAA) First-Quarter Results Just Came Out: Here's What Analysts Are Forecasting For This Year
Aug 10Krsnaa Diagnostics' (NSE:KRSNAA) Dividend Is Being Reduced To ₹2.50
Aug 09Krsnaa Diagnostics Limited's (NSE:KRSNAA) 28% Jump Shows Its Popularity With Investors
Jul 05Here's What To Make Of Krsnaa Diagnostics' (NSE:KRSNAA) Decelerating Rates Of Return
Jun 16We Think That There Are More Issues For Krsnaa Diagnostics (NSE:KRSNAA) Than Just Sluggish Earnings
May 26Is Krsnaa Diagnostics (NSE:KRSNAA) A Risky Investment?
Mar 14Krsnaa Diagnostics Limited Just Missed Earnings - But Analysts Have Updated Their Models
Feb 16Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 31Krsnaa Diagnostics (NSE:KRSNAA) Will Pay A Larger Dividend Than Last Year At ₹2.75
Aug 17Returns On Capital Are Showing Encouraging Signs At Krsnaa Diagnostics (NSE:KRSNAA)
Jun 03Revenue Miss: Krsnaa Diagnostics Limited Fell 6.4% Short Of Analyst Revenue Estimates And Analysts Have Been Revising Their Models
Feb 17Take Care Before Diving Into The Deep End On Krsnaa Diagnostics Limited (NSE:KRSNAA)
Feb 16Krsnaa Diagnostics' (NSE:KRSNAA) Anemic Earnings Might Be Worse Than You Think
Nov 17Financial Position Analysis
Short Term Liabilities: KRSNAA's short term assets (₹4.2B) exceed its short term liabilities (₹3.8B).
Long Term Liabilities: KRSNAA's short term assets (₹4.2B) exceed its long term liabilities (₹726.5M).
Debt to Equity History and Analysis
Debt Level: KRSNAA's net debt to equity ratio (18.3%) is considered satisfactory.
Reducing Debt: KRSNAA had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Debt Coverage: KRSNAA's debt is well covered by operating cash flow (20.3%).
Interest Coverage: KRSNAA's interest payments on its debt are well covered by EBIT (16.1x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/12 11:53 |
| End of Day Share Price | 2025/05/12 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Krsnaa Diagnostics Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Hrishikesh Patole | Batlivala & Karani Securities India Pvt. Ltd. |
| Bharat Celly | Equirus Securities Private Limited |
| Cyndrella Carvalho | JM Financial Institutional Securities Limited |